Clinical Trial Update: Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ammonium lactate 12% lotion (Lac-Hydrin) and halobetasol propionate 0.05% ointment (Ultravate) for the treatment and maintenan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Lac-Hydrin (ammonium lactate)
• Ultravate (halobetasol propionate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2016-06-24